Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03296592 · ClinicalTrials.gov registry record
Diffusion MRI in Cervical Spondylotic Myelopathy (CSM)
A clinical trial, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 71
- Enrollment target
NCT03296592 is a clinical trial that has completed, run by Washington University School of Medicine. The registered enrollment target is 71 participants.
The verdict
NCT03296592 has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 71 participants
- Enrollment target
Study Summary
Patients who have been diagnosed with Cervical Spondylotic Myelopathy will be asked to undergo an MRI using diffusion basis spectrum imaging (DBSI) technology. The patients will have this MRI preoperatively and at 24 months postop. The investigators believe that with this imaging, biomarkers will be able to be seen to assist in prediction of long term outcomes in patients with spinal cord compression. These patients will be compared to healthy cohorts who will also undergo an MRI using the DBSI technology.
Interventions
- DIAGNOSTIC_TEST MRI with DBSI technology
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2018-01-29 |
| Est. Completion | 2025-12-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03296592
The ClinicalTrials.gov registry entry for NCT03296592 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 71 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MRI with DBSI technology is the first listed.
NCT03296592 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03296592 about?
NCT03296592 is a clinical study titled "Diffusion MRI in Cervical Spondylotic Myelopathy (CSM)". Patients who have been diagnosed with Cervical Spondylotic Myelopathy will be asked to undergo an MRI using diffusion basis spectrum imaging (DBSI) technology. The patients will have this MRI preoperatively and at 24 months postop. The investigators believe that with this imaging, biomarkers will be...
What is the current status of trial NCT03296592?
This trial is currently completed. The enrollment target is 71 participants. The study started on 2018-01-29. Estimated completion is 2025-12-29.
What interventions are being tested in trial NCT03296592?
The interventions under investigation include: MRI with DBSI technology (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03296592?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.